查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363100

藥品穩定和儲存服務北美和歐洲市場規模、佔有率和趨勢分析報告：按服務、分子、模式、地區和細分市場預測，2023-2030 年

North America And Europe Pharmaceutical Stability & Storage Services Market Size, Share & Trends Analysis Report By Services (Stability, Storage), By Molecule (Large Molecule, Small Molecule), By Mode, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 133 Pages | 商品交期: 2-10個工作天內

價格

北美和歐洲藥品穩定和儲存服務市場成長和趨勢：

Grand View Research, Inc. 的最新報告顯示，到2030年，北美和歐洲的藥品穩定和儲存服務市場規模預計將達到 32.2 億美元。

預計2023年至2030年該市場將以5.5%的年複合成長率成長。嚴格的法規要求，不斷增加的研發投資和臨床試驗的全球化是推動市場成長的關鍵要素。

生物相似藥需求的成長預計將推動市場進步。近年來，生物相似藥的核准率顯著提高。根據2020年發布的Amgen Biosimilars Trend Report，美國核准的生物類似藥數量較上一年成長了65%，截至2023年，美國已核准41種產品，美國已批准70多種產品。歐盟。擴大生物相似藥的核准可能會對市場產生積極影響。

藥物穩定性在決定藥物的強度和有效性方面發揮重要作用。然而，確保穩定性受到法規機構不同的資料要求和測試法規的挑戰，使得產品在不同地區的銷售尤其困難。儘管 EMA 和 FDA 都遵守 ICH 穩定性測試指南，但這些測試具有不同的微生物極限。因此，某些在美國可選的評估可能在歐盟成為強制性的，反之亦然。這些差異使穩定性測試程序變得複雜，並增加了外包此類測試服務的需求。

一些公司採取收購、合作和推出新服務等策略來獲得市場地位。例如，2023年 3月，BioLife Solutions 推出了 Ultraguard-70°C 相變材料 (PCM) 配件，為 ULT 冰箱提供備用冷卻，並作為桌面生物製藥存放的乾冰替代。此外，2022年 10月，CSafe 和 BioLife Solutions, Inc. 建立了合作夥伴關係，以增強細胞和基因治療供應鏈解決方案。 CSafe 加入 BioLife 的全球合作夥伴網路，為細胞和基因療法市場提供冷鏈解決方案。

北美和歐洲藥品穩定和儲存服務市場報告亮點：

  • 到2022年，穩定領域將主導區域市場，生物製藥和個體化藥物需求的激增將推動藥物穩定性服務的進步。
  • 依服務分類，由於發展中地區對學名藥和生物學名藥的關注度不斷提高，儲存領域預計在預測期內年複合成長率為 6.1%。
  • 2022年的市場將由小分子領域主導。預測、基於結構的設計、成像、自動化、人工智慧和機器學習的最新進展是提高小分子先導化合物最佳化的步伐和成功率的關鍵促進因素。
  • 聚合物領域也在市場上佔有重要佔有率。這是由於擴大採用蛋白質、核酸、碳水化合物、生物細胞和組織等大分子。
  • 2022年，自家公司部門佔據最大市場佔有率。大多數藥廠選擇在自家公司進行穩定性測試。所有藥物和臨床試驗的所有階段都需要進行這些測試。
  • 北美市場佔據主導地位，2022年銷售佔有率最大，為 71.51%。這是因為該地區有幾家主要市場參與者提供穩定性測試和儲存服務。
  • 預計歐洲在未來年度也將佔很大比例。英國注重醫藥領域的研發。隨著公司投資開發新藥和進行臨床試驗，對支援這些活動的穩定性測試和儲存服務的需求不斷成長。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 藥物穩定與儲存服務市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 附隨市場預測
  • 藥物穩定與儲存服務市場
  • 市場動態
    • 市場促進因素影響分析
    • 市場抑制因素分析
    • 產業趨勢
    • 機會分析
  • 波特五力分析
  • PESTEL分析
  • COVID-19 對北美和歐洲藥品穩定和儲存服務市場的影響

第4章 北美和歐洲藥品穩定和儲存服務市場：2018-2030年依服務分類的細分分析

  • 北美和歐洲藥品穩定和儲存服務市場：服務變化分析
  • 依服務
  • 穩定
  • 貯存

第5章 北美和歐洲藥物穩定和儲存服務市場：2018-2030年分子細分分析

  • 北美和歐洲分子藥物穩定和儲存服務市場：要點
  • 2022年和2030年分子變異分析和市場佔有率
  • 按分子分類
  • 低分子
  • 高分子

第6章 北美和歐洲藥品穩定和儲存服務市場：按模式細分分析，2018-2030

  • 北美和歐洲藥品穩定和儲存服務市場（按模式）：要點
  • 2022年和2030年模式變化分析和市場佔有率
  • 按模式
  • 公司內部
  • 外包

第7章 北美和歐洲藥物穩定和儲存服務市場：依服務、分子和模式進行區域估計和趨勢分析

  • 北美和歐洲藥品穩定和儲存服務市場：區域展望
  • 北美洲
  • 歐洲

第8章 競爭形勢

  • 熱圖分析
  • 參與企業概況
  • 財務實績
  • 服務標竿
  • 策略規劃
    • 獲得
    • 擴張
    • 夥伴關係與協作
    • 產品發表會
  • 公司市場佔有率分析（2022年）
  • 公司名錄
Product Code: GVR-4-68040-123-7

North America And Europe Pharmaceutical Stability & Storage Services Market Growth & Trends:

The North America and Europe pharmaceutical stability & storage services market size is expected to reach USD 3.22 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to grow at a CAGR of 5.5% from 2023 to 2030. Stringent regulatory requirements, increasing R&D investments, and globalization of clinical trials are some of the major factors driving market growth.

The rising demand for biosimilars is expected to drive market advancement. In recent years, the approval rate for biosimilars has significantly improved. As per the Amgen Biosimilars Trend Report published in 2020, there was an increase in the number of biosimilar approvals by 65% since the preceding year in the U.S. As of 2023, 41 biosimilars were approved in the U.S., and over 70 were approved in the EU. The growing approval of biosimilars is likely to positively impact the market.

The stability of pharmaceuticals plays a crucial role in determining the strength and effectiveness of the medication. However, ensuring stability poses challenges due to varying data requirements and testing regulations imposed by different regulatory bodies, making it particularly difficult to market products in diverse regions. While both the EMA and FDA adhere to the ICH guidelines for stability testing, they maintain distinct microbiological limits for these tests. Consequently, certain evaluations that are optional in the United States become mandatory in the European Union, and vice versa. These disparities complicate stability testing procedures, leading to an increased need for outsourcing such testing services.

Several companies are involved in strategies such as acquisitions, collaborations, and new service launches to gain positions in the market. For instance, in March 2023, BioLife Solutions introduced the Ultraguard -70°C Phase Change Material (PCM) Accessory to offer backup cooling in ULT Freezers and act as a dry ice substitute for benchtop biologic material storage. Moreover, in October 2022, CSafe and BioLife Solutions, Inc. formed a partnership to enhance supply chain solutions for cell and gene therapy. CSafe joined BioLife's global partner network of companies offering cold chain solutions for the cell and gene therapies market.

North America And Europe Pharmaceutical Stability & Storage Services Market Report Highlights:

  • The stability segment dominated the regional market in 2022. The rapid growth in the demand for biopharmaceuticals and personalized medicines is driving advancements in pharmaceutical stability services
  • Based on service, the storage segment is expected to witness the highest CAGR of 6.1% over the forecast period, owing to the increasing focus on generics and biosimilars in developing regions
  • The small molecules segment dominated the market in 2022. Recent advances in forecasting, structure-based design, imaging, automation, artificial intelligence, and machine learning have become critical facilitators for increasing small molecule lead optimization's pace and success rates
  • The large molecule segment also holds a significant share in the market. This is due to the increasing adoption of large molecules such as proteins, nucleic acids, carbohydrates, living cells, and tissues
  • In 2022, the in-house segment held the largest market share. Most pharmaceutical manufacturers choose in-house stability testing, as these tests are required to be performed for all drugs and in all phases of clinical studies
  • North America dominated the market, accounting for the largest revenue share of 71.51% in 2022, due to the presence of several major market players providing stability and storage services in the region
  • Europe is also expected to account for a significant share of the market in the coming years. The UK has a strong emphasis on R&D in the pharmaceutical sector. As companies invest in developing new drugs and conducting clinical trials, there is an increased demand for stability testing and storage services to support these activities

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Market Definitions
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Information analysis
    • 1.4.2 Market formulation & data visualization
    • 1.4.3 Data validation & publishing
  • 1.5 Research Scope and Assumptions
    • 1.5.1 Approach 1: Commodity Flow Analysis
    • 1.5.2 Approach 2: Hybrid Model Analysis
    • 1.5.3 Hybrid Model market estimation
    • 1.5.4 Region/Country-based segment share calculation
    • 1.5.5 Multivariate analysis
    • 1.5.6 CAGR Calculation
  • 1.6 List of Secondary Sources
  • 1.7 Objectives
    • 1.7.1 Objective - 1
    • 1.7.2 Objective - 2
    • 1.7.3 Objective - 3
    • 1.7.4 Objective - 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Segment Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Pharmaceutical Stability & Storage Services Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Pharmaceutical Stability & Storage Services Market
  • 3.3 Market Dynamics
    • 3.3.1 Market driver impact analysis
      • 3.3.1.1 High R&D spending of pharmaceutical & biotechnology companies
      • 3.3.1.2 Growing demand for outsourcing stability testing due to the high complexity associated with drug stability
      • 3.3.1.3 Growing demand for biosimilars
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Stringent regulations for Pharmaceutical Stability and Storage Services of drugs
      • 3.3.2.2 Issues Associated with stability chambers
    • 3.3.3 Industry Trends
      • 3.3.3.1 Expansion of cold chain logistics
    • 3.3.4 Opportunity Analysis
      • 3.3.4.1 Increasing demand for personalized medicine
  • 3.4 Porter's Five Forces Analysis
  • 3.5 PESTEL Analysis
  • 3.6 Impact of COVID-19 on North America and Europe Pharmaceutical Stability & Storage Services Market

Chapter 4 North America and Europe Pharmaceutical Stability & Storage Services Market: Segment Analysis, by Services, 2018 - 2030 (USD Million)

  • 4.1 North America and Europe Pharmaceutical Stability & Storage Services Market: Services Movement Analysis
  • 4.2 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Services (USD Million)
    • 4.2.1 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Stability Type (USD Million)
    • 4.2.2 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Storage Type (USD Million)
  • 4.3 Stability
    • 4.3.1 Drug Substance
    • 4.3.2 Stability indicating method validation
    • 4.3.3 Accelerated stability testing
    • 4.3.4 Photostability Testing
    • 4.3.5 Other stability testing methods
  • 4.4 Storage
    • 4.4.1 Cold
    • 4.4.2 Non-cold

Chapter 5 North America and Europe Pharmaceutical Stability & Storage Services Market: Segment Analysis, by Molecule, 2018 - 2030 (USD Million)

  • 5.1 North America and Europe Pharmaceutical Stability & Storage Services Market by Molecule: Key Takeaways
  • 5.2 Molecule Movement Analysis & Market Share, 2022 & 2030
  • 5.3 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Molecule (USD Million)
    • 5.3.1 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Small Molecules (USD Million)
    • 5.3.2 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Large Molecules (USD Million)
  • 5.4 Small Molecule
    • 5.4.1 Small Molecule market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2 Research Products
      • 5.4.2.1 Research Products market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3 Commercial Products
      • 5.4.3.1 Commercial Products market estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5 Large Molecule
    • 5.5.1 Large Molecule market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2 Research Products
      • 5.5.2.1 Research Products market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3 Commercial Products
      • 5.5.3.1 Commercial Products market estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6 North America and Europe Pharmaceutical Stability & Storage Services Market: Segment Analysis, by Mode, 2018 - 2030 (USD Million)

  • 6.1 North America and Europe Pharmaceutical Stability & Storage Services Market by Mode: Key Takeaways
  • 6.2 Mode Movement Analysis & Market Share, 2022 & 2030
  • 6.3 North America and Europe Pharmaceutical Stability & Storage Services Market Estimates & Forecast, By Mode (USD Million)
  • 6.4 In-House
    • 6.4.1 In-House market estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5 Outsourcing
    • 6.5.1 Outsourcing market estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7 North America and Europe Pharmaceutical Stability & Storage Services Market: Regional Estimates and Trend Analysis, by Services, by Molecule, by Mode.

  • 7.1 North America and Europe Pharmaceutical Stability & Storage Services Market: Regional Outlook
  • 7.2 North America
      • 7.2.1.1 North America Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 Key Country Dynamics
      • 7.2.2.2 Competitive Scenario
      • 7.2.2.3 Regulatory Framework
      • 7.2.2.4 U.S. Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Key Country Dynamics
      • 7.2.3.2 Competitive Scenario
      • 7.2.3.3 Regulatory Framework
      • 7.2.3.2 Canada Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3 Europe
      • 7.3.1.1 Europe Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2 UK
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 Competitive Scenario
      • 7.3.2.3 Regulatory Framework
      • 7.3.2.4 UK Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Competitive Scenario
      • 7.3.3.3 Regulatory Framework
      • 7.3.3.4 Germany Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 Key Country Dynamics
      • 7.3.4.2 Competitive Scenario
      • 7.3.4.3 Regulatory Framework
      • 7.3.4.4 France Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Key Country Dynamics
      • 7.3.5.2 Competitive Scenario
      • 7.3.5.3 Regulatory Framework
      • 7.3.5.4 Italy Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million
    • 7.3.6 Spain
      • 7.3.6.1 Key Country Dynamics
      • 7.3.6.2 Competitive Scenario
      • 7.3.6.3 Regulatory Framework
      • 7.3.6.4 Spain Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million
    • 7.3.7 Denmark
      • 7.3.7.1 Key Country Dynamics
      • 7.3.7.2 Competitive Scenario
      • 7.3.7.3 Regulatory Framework
      • 7.3.7.4 Denmark Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million
    • 7.3.8 Sweden
      • 7.3.8.1 Key Country Dynamics
      • 7.3.8.2 Competitive Scenario
      • 7.3.8.3 Regulatory Framework
      • 7.3.8.4 Sweden Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million
    • 7.3.9 Norway
      • 7.3.9.1 Key Country Dynamics
      • 7.3.9.2 Competitive Scenario
      • 7.3.9.3 Regulatory Framework
      • 7.3.9.4 Norway Pharmaceutical Stability & Storage Services market estimates and Forecasts, 2018 - 2030 (USD Million

Chapter 8 Competitive Landscape

  • 8.1 Heat Map Analysis
  • 8.2 Participants Overview
  • 8.3 Financial Performance
  • 8.4 Service Benchmarking
  • 8.5 Strategy Mapping
    • 8.5.1 Acquisition
    • 8.5.2 Expansion
    • 8.5.3 Partnership & Collaboration
    • 8.5.4 Product Launch
  • 8.6 Company Market Share Analysis (2022)
  • 8.7 List of Players

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. North America and Europe Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 4. North America and Europe Pharmaceutical Stability & Storage Services Market by Molecule, 2018 - 2030 (USD Million)
  • Table 5. North America and Europe Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 6. North America and Europe Pharmaceutical Stability & Storage Services Market by Region, 2018 - 2030 (USD Million)
  • Table 7. North America Pharmaceutical Stability & Storage Services Market by Country, 2018 - 2030 (USD Million)
  • Table 8. North America Pharmaceutical Stability & Storage Services Market by Service, 2018 - 2030 (USD Million)
  • Table 9. North America Pharmaceutical Stability & Storage Services Market by Molecule, 2018-2030 (USD Million)
  • Table 10. North America Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 11. U.S. Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 12. U.S. Pharmaceutical Stability & Storage Services Market by Molecule, 2018 - 2030 (USD Million)
  • Table 13. U.S. Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 14. Canada Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 15. Canada Pharmaceutical Stability & Storage Services Market by Molecule, 2018 - 2030 (USD Million)
  • Table 16. Canada Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 17. Europe Pharmaceutical Stability & Storage Services Market by Country, 2018 - 2030 (USD Million)
  • Table 18. Europe Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 19. Europe Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 20. Europe Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 21. Germany Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 22. Germany Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 23. Germany Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 24. UK Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 25. UK Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 26. UK Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 27. France Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 28. France Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 29. France Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 30. Italy Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 31. Italy Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 32. Italy Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 33. Spain Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 34. Spain Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 35. Spain Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 36. Denmark Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 37. Denmark Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 38. Denmark Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 39. Sweden Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 40. Sweden Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 41. Sweden Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)
  • Table 42. Norway Pharmaceutical Stability & Storage Services Market by Services, 2018 - 2030 (USD Million)
  • Table 43. Norway Pharmaceutical Stability & Storage Services Market by Molecules, 2018 - 2030 (USD Million)
  • Table 44. Norway Pharmaceutical Stability & Storage Services Market by Mode, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Pharmaceutical Stability & Storage Services Market: Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Market Penetration vs. Growth Prospect Mapping, 2021
  • Fig. 14 Regional Marketplace: Key Takeaways
  • Fig. 15 North America and Europe Pharmaceutical Stability & Storage Services Market for Stability, 2018 - 2030 (USD Million)
  • Fig. 16 North America and Europe Pharmaceutical Stability & Storage Services Market for Drug Substance, 2018 - 2030 (USD Million)
  • Fig. 17 North America and Europe Pharmaceutical Stability & Storage Services Market for Stability indicating method validation , 2018 - 2030 (USD Million)
  • Fig. 18 North America and Europe Pharmaceutical Stability & Storage Services Market for Accelerated stability testing , 2018 - 2030 (USD Million)
  • Fig. 19 North America and Europe Pharmaceutical Stability & Storage Services Market for Photostability Testing , 2018 - 2030 (USD Million)
  • Fig. 20 North America and Europe Pharmaceutical Stability & Storage Services Market for Other stability testing methods, 2018 - 2030 (USD Million)
  • Fig. 21 North America and Europe Pharmaceutical Stability & Storage Services Market for Storage, 2018 - 2030 (USD Million)
  • Fig. 22 North America and Europe Pharmaceutical Stability & Storage Services Market for Cold storage, 2018 - 2030 (USD Million)
  • Fig. 23 North America and Europe Pharmaceutical Stability & Storage Services Market for Non-cold storage, 2018 - 2030 (USD Million)
  • Fig. 24 North America and Europe Pharmaceutical Stability & Storage Services Market for Small Molecule, 2018 - 2030 (USD Million)
  • Fig. 25 North America and Europe Pharmaceutical Stability & Storage Services Market for Research Products, 2018 - 2030 (USD Million)
  • Fig. 26 North America and Europe Pharmaceutical Stability & Storage Services Market for Commercial Products, 2018 - 2030 (USD Million)
  • Fig. 27 North America and Europe Pharmaceutical Stability & Storage Services Market for Large Molecule, 2018 - 2030 (USD Million)
  • Fig. 28 North America and Europe Pharmaceutical Stability & Storage Services Market for Research Products, 2018 - 2030 (USD Million)
  • Fig. 29 North America and Europe Pharmaceutical Stability & Storage Services Market for Commercial Products, 2018 - 2030 (USD Million)
  • Fig. 30 North America and Europe Pharmaceutical Stability & Storage Services Market for In-house services, 2018 - 2030 (USD Million)
  • Fig. 31 North America and Europe Pharmaceutical Stability & Storage Services Market for Outsourcing services, 2018 - 2030 (USD Million)
  • Fig. 32 Regional Outlook, 2021 & 2030
  • Fig. 33 North America Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway Pharmaceutical Stability & Storage Services Market, 2018 - 2030 (USD Million)